{
  "CitationSubset": [],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "23520801",
  "DateCompleted": {
    "Year": "2013",
    "Month": "06",
    "Day": "20"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "09",
    "Day": "23"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1547-1896",
      "JournalIssue": {
        "Volume": "26",
        "Issue": "3",
        "PubDate": {
          "Year": "2013",
          "Month": "Mar"
        }
      },
      "Title": "JAAPA : official journal of the American Academy of Physician Assistants",
      "ISOAbbreviation": "JAAPA"
    },
    "ArticleTitle": "Nontuberculous mycobacterial infections: in vitro growth rates are clues to sites and susceptibility.",
    "Pagination": {
      "StartPage": "18",
      "EndPage": "25",
      "MedlinePgn": "18, 25"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Infectious Diseases, Infection Control and Employee Health, University of Texas M.D. Anderson Cancer Center, Houston, USA."
          }
        ],
        "LastName": "Borchardt",
        "ForeName": "Roy A",
        "Initials": "RA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Rolston",
        "ForeName": "Kenneth V I",
        "Initials": "KV"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "JAAPA",
    "NlmUniqueID": "9513102",
    "ISSNLinking": "0893-7400"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antitubercular Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Infective Agents"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antitubercular Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Resistance, Bacterial"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunocompromised Host"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Incidence"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Microbial Sensitivity Tests"
    },
    {
      "QualifierName": [
        "growth & development",
        "pathogenicity"
      ],
      "DescriptorName": "Mycobacterium"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology"
      ],
      "DescriptorName": "Mycobacterium Infections, Nontuberculous"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology"
      ],
      "DescriptorName": "Opportunistic Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prevalence"
    }
  ]
}